Target intelligence / Profile preview

Nuclease EXOG, mitochondrial (EXOG)

Target
EXOG
Molecular classification
Enzyme, Nuclease (Endonuclease and Exonuclease), Mitochondrial protein
01

Overview

Nuclease EXOG, mitochondrial (EXOG) is a dimeric mitochondrial enzyme in humans that functions with both 5′–3′ exonuclease and endonuclease activity, with a preference for single-stranded DNA but can also nick supercoiled DNA. It is essential for mitochondrial DNA repair, including removal of RNA primers during DNA replication and repair of mtDNA, and may play roles in programmed cell death and normal cell proliferation. EXOG is encoded by a nuclear gene but localizes to the inner mitochondrial membrane through a hydrophobic N-terminal transmembrane segment. It complements the related Endonuclease G (EndoG), which in mammals is a pure endonuclease; together these two enzymes likely cover all major mitochondrial nucleic acid metabolism functions in higher eukaryotes. SNPs in or near the EXOG gene have been associated with risk for certain diseases, such as type II diabetes, emphasizing its importance in mitochondrial integrity and cellular health. No drugs or clinical inhibitors specifically target EXOG according to current evidence.

Other names
Endonuclease G-like 1Endonuclease G-like 2ENDOGL1ENDOGL2ENGLENGL-aENGL-bENGLAENGLBexo/endonuclease GEndo G-like 1endo/exonuclease (5'-3')endonuclease G-likenuclease EXOG, mitochondrial
02

Biological functions

Mitochondrial DNA repair (removes RNA primers, involved in mtDNA maintenance)5′–3′ exonuclease activity (hydrolyzes ester linkages at the 5' end of nucleic acids)Endonuclease activity (nicks supercoiled DNA, prefers single-stranded DNA)Programmed cell death (apoptosis)Cell proliferation
03

Disease associations

Type II diabetes (associated SNPs)Brugada SyndromeOther mitochondrial dysfunctions (potential roles by analogy to EndoG)
04

Safety considerations

Genetic loss or dysfunction may affect mitochondrial DNA repair leading to disease or cell deathNo direct therapeutic usage or safety liability reported for existing drugs targeting EXOG
05

Biomarkers

SNPs in EXOG gene (associated with type II diabetes)Not established as standard biomarker for patient selection or efficacy

Beyond the preview

Go deeper on Nuclease EXOG, mitochondrial (EXOG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclease EXOG, mitochondrial (EXOG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call